Vident Investment Advisory, LLC Compugen LTD Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.57 - $1.38 $8,195 - $19,841
14,378 Added 48.43%
44,066 $50,000
Q1 2023

May 15, 2023
BUY
$0.68 - $1.11 $20,187 - $32,953
29,688 New
29,688 $20,000
Q4 2020

Feb 08, 2021
SELL
$12.07 - $17.95 $1.21 Million - $1.8 Million
-100,258 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$14.16 - $19.45 $47,322 - $65,001
-3,342 Reduced 3.23%
100,258 $1.63 Million
Q2 2020

Jul 17, 2020
BUY
$6.97 - $17.12 $722,092 - $1.77 Million
103,600 New
103,600 $1.56 Million

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $131M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email